Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

HIV

The human immunodeficiency viruses type 1 and type 2 (HIV 1+2) are the etiological agents of the acquired immunodeficiency syndrome (AIDS) and related conditions. HIV has been isolated from patients with AIDS, AIDS related complex (ARC) and from healthy individuals at high risk for AIDS. Infection with HIV is followed by an acute flu-like illness. This phase may remain unnoticed and the relationship to HIV infection may not be clear in many cases. The acute phase is typically followed by an asymptomatic carrier state, which progresses to clinical AIDS in about 50% of infected individuals within 10 years after seroconversion.

The Biorex Diagnostics HIV ELISA kits are an enzyme-linked immunosorbent assay (ELISA) intended for qualitative detection of antibodies to Human Immunodeficiency Viruses (HIV) type 1 (group M – O) or type 2 in human serum or plasma specimens. The assay can be utilized for screening of blood donors and/or as an aid in the diagnosis of clinical conditions related to infection with HIV-1 and /or HIV-2 – the etiological agents of the acquired immunodeficiency syndrome (AIDS). The Fortress HIV Anti HCV (4th Gen) kits are intended for use in screening blood donors and diagnosing patients related to the infection with hepatitis C virus.

Add to Quote

Description

Product Name CAT.No Size
HIV 1+2 3rd Gen BXE0791A 96T
HIV 1+2 3rd Gen BXE0791C 480T
HIV Ag/Ab 4th Gen BXE0792A 96T
HIV Ag/Ab 4th Gen BXE0792C 480T
HIV 1+2 ELISA (with CE) BXE0793A 96T
HIV 1+2 ELISA (with CE) BXE0793C 480T

 

 

Product Description

The Biorex Diagnostics HIV 1/2 ELISA kit is a highly sensitive and specific microplate enzyme-linked immunosorbent assay (ELISA) designed for the qualitative detection of antibodies to Human Immunodeficiency Virus types 1 and 2 (HIV-1 and HIV-2) in human serum or plasma. HIV-1 and HIV-2 are the causative agents of Acquired Immunodeficiency Syndrome (AIDS) and related immunodeficiency conditions. Following infection, HIV often triggers an acute flu-like illness that may go unnoticed, followed by a prolonged asymptomatic phase during which the virus replicates silently. Without timely intervention, infected individuals face progressive immune system deterioration, opportunistic infections, and increased risk of malignancies.

Early and accurate detection of HIV antibodies is essential for patient care, blood safety, and public health. The Biorex HIV ELISA kit allows laboratories to identify infected individuals promptly, enabling early initiation of antiretroviral therapy (ART), reducing transmission risk, and supporting epidemiological surveillance. The assay is suitable for clinical diagnosis, blood donor screening, and research applications, providing reliable qualitative results for HIV-1 (groups M–O) and HIV-2 antibodies.

Key Features

  • Qualitative Microplate ELISA – enables sensitive and specific detection of HIV-1 and HIV-2 antibodies.
  • High Sensitivity and Specificity – reduces false negatives and false positives, ensuring accurate diagnosis.
  • Serum and Plasma Compatibility – optimized for routine clinical and blood bank testing.
  • Reliable Reproducibility – consistent performance across multiple assay runs and operators.
  • Comprehensive Kit Components – includes ready-to-use reagents, controls, and standards for streamlined workflow.
  • Versatile Application – suitable for diagnostics, blood donor screening, epidemiological studies, and research.

The Biorex Diagnostics HIV ELISA kits provide a trusted, accurate, and efficient solution for laboratories and healthcare providers worldwide. By enabling the early detection of HIV antibodies, these assays support patient management, preventive healthcare, and public health initiatives. Their robust performance and user-friendly workflow make them ideal for clinical laboratories, blood banks, and research centres, contributing to improved patient outcomes, safer blood supplies, and enhanced global HIV surveillance efforts.

Contact Us for more information

Additional information

Storage

2-8°C